301 related articles for article (PubMed ID: 11377677)
21. Differential diagnoses of systemic mastocytosis in routinely processed bone marrow biopsy specimens: a review.
Horny HP; Sotlar K; Valent P
Pathobiology; 2010; 77(4):169-80. PubMed ID: 20616612
[TBL] [Abstract][Full Text] [Related]
22. Standards of Pathology in the Diagnosis of Systemic Mastocytosis: Recommendations of the EU-US Cooperative Group.
Sotlar K; George TI; Kluin P; Reiter A; Schwaab J; Panse J; Brockow K; Hartmann K; Sperr WR; Kristensen T; Nedoszytko B; Carter M; Bonadonna P; Lyons JJ; Kluin-Nelemans HC; Hermine O; Akin C; Broesby-Olsen S; Hoermann G; Triggiani M; Butterfield JH; Jawhar M; Gotlib J; Metcalfe DD; Orfao A; Arock M; Valent P; Horny HP
J Allergy Clin Immunol Pract; 2022 Aug; 10(8):1986-1998.e2. PubMed ID: 35724949
[TBL] [Abstract][Full Text] [Related]
23. [Diagnosis of systemic mastocytosis using a semiquantitative method of assessing the mast cell population].
Tomilov AF; Podivilova TN
Ter Arkh; 1990; 62(4):108-11. PubMed ID: 2392747
[TBL] [Abstract][Full Text] [Related]
24. Diagnosis and classification of mast cell proliferative disorders: delineation from immunologic diseases and non-mast cell hematopoietic neoplasms.
Valent P; Sperr WR; Schwartz LB; Horny HP
J Allergy Clin Immunol; 2004 Jul; 114(1):3-11; quiz 12. PubMed ID: 15241337
[TBL] [Abstract][Full Text] [Related]
25. Myelomastocytic leukemia versus mast cell leukemia versus systemic mastocytosis associated with acute myeloid leukemia: a diagnostic challenge.
Arredondo AR; Gotlib J; Shier L; Medeiros B; Wong K; Cherry A; Corless C; Arber DA; Valent P; George TI
Am J Hematol; 2010 Aug; 85(8):600-6. PubMed ID: 20658589
[No Abstract] [Full Text] [Related]
26. De novo mast cell leukemia without CD25 expression and KIT mutations: a rare case report in a 13-year-old child.
Zheng Y; Nong L; Liang L; Wang W; Li T
Diagn Pathol; 2018 Feb; 13(1):14. PubMed ID: 29458385
[TBL] [Abstract][Full Text] [Related]
27. Delineation of patterns of bone marrow mast cell infiltration in systemic mastocytosis: value of CD25, correlation with subvariants of the disease, and separation from mast cell hyperplasia.
Krokowski M; Sotlar K; Krauth MT; Födinger M; Valent P; Horny HP
Am J Clin Pathol; 2005 Oct; 124(4):560-8. PubMed ID: 16146815
[TBL] [Abstract][Full Text] [Related]
28. Impact of centralized evaluation of bone marrow histology in systemic mastocytosis.
Jawhar M; Schwaab J; Horny HP; Sotlar K; Naumann N; Fabarius A; Valent P; Cross NC; Hofmann WK; Metzgeroth G; Reiter A
Eur J Clin Invest; 2016 May; 46(5):392-7. PubMed ID: 26914980
[TBL] [Abstract][Full Text] [Related]
29. Mast cell leukemia: report of a case and review of the literature.
Travis WD; Li CY; Hoagland HC; Travis LB; Banks PM
Mayo Clin Proc; 1986 Dec; 61(12):957-66. PubMed ID: 3095598
[TBL] [Abstract][Full Text] [Related]
30. [Mastocytosis, classification, biological diagnosis and therapy].
Arock M
Ann Biol Clin (Paris); 2004; 62(6):657-69. PubMed ID: 15563424
[TBL] [Abstract][Full Text] [Related]
31. Protease profile of normal and neoplastic mast cells in the human bone marrow with special emphasis on systemic mastocytosis.
Atiakshin D; Buchwalow I; Horny P; Tiemann M
Histochem Cell Biol; 2021 May; 155(5):561-580. PubMed ID: 33492488
[TBL] [Abstract][Full Text] [Related]
32. Systemic mastocytosis in adults: 2012 Update on diagnosis, risk stratification, and management.
Pardanani A
Am J Hematol; 2012 Apr; 87(4):401-11. PubMed ID: 22410759
[TBL] [Abstract][Full Text] [Related]
33. Sequential immunophenotypic analysis of mast cells in a case of systemic mast cell disease evolving to a mast cell leukemia.
Escribano L; Orfao A; Villarrubia J; Martín F; Madruga JI; Cuevas M; Velasco JL; Rios A; San Miguel JF
Cytometry; 1997 Apr; 30(2):98-102. PubMed ID: 9149916
[TBL] [Abstract][Full Text] [Related]
34. Mast cell differentiation of leukemic blasts in diverse myeloid neoplasms: A potential pre-myelomastocytic leukemia condition.
Panda D; Chatterjee G; Khanka T; Ghogale S; Badrinath Y; Deshpande N; Sardana R; Chaturvedi A; Rajpal S; Shetty D; Patkar NV; Gujral S; Subramanian PG; Tembhare PR
Cytometry B Clin Cytom; 2021 May; 100(3):331-344. PubMed ID: 32738100
[TBL] [Abstract][Full Text] [Related]
35. [Mast cell leukemia--case report].
Vasilj A; Katović SK; Maricević I; Zokvić E; Gaćina P
Acta Med Croatica; 2013 Mar; 67(1):61-4. PubMed ID: 24279257
[TBL] [Abstract][Full Text] [Related]
36. Clinical and biologic diversity of leukemias occurring in patients with mastocytosis.
Sperr WR; Horny HP; Lechner K; Valent P
Leuk Lymphoma; 2000 May; 37(5-6):473-86. PubMed ID: 11042508
[TBL] [Abstract][Full Text] [Related]
37. Bone marrow findings in systemic mastocytosis.
Horny HP; Parwaresch MR; Lennert K
Hum Pathol; 1985 Aug; 16(8):808-14. PubMed ID: 3860469
[TBL] [Abstract][Full Text] [Related]
38. Mastocytosis, MCAS, and Related Disorders-Diagnosis, Classification, and Therapy.
Niedoszytko M; Valent P; Nedoszytko B
Int J Mol Sci; 2021 May; 22(9):. PubMed ID: 34068468
[TBL] [Abstract][Full Text] [Related]
39. Frequency and prognostic impact of blood-circulating tumor mast cells in mastocytosis.
Henriques A; Muñoz-González JI; Sánchez-Muñoz L; Matito A; Torres-Rivera L; Jara-Acevedo M; Caldas C; Mayado A; Pérez-Pons A; García-Montero AC; Álvarez-Twose I; Orfao A
Blood; 2022 Jan; 139(4):572-583. PubMed ID: 34496018
[TBL] [Abstract][Full Text] [Related]
40. The tryptase positive compact round cell infiltrate of the bone marrow (TROCI-BM): a novel histopathological finding requiring the application of lineage specific markers.
Horny HP; Sotlar K; Stellmacher F; Krokowski M; Agis H; Schwartz LB; Valent P
J Clin Pathol; 2006 Mar; 59(3):298-302. PubMed ID: 16505282
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
